India's rising twin birth rate, driven by assisted reproductive technologies and delayed childbearing, generates approximately 30,000-40,000 twin pairs annually, yet this invaluable research resource remains systematically underutilized. While established twin registries in the United Kingdom, Australia, and Nordic countries have transformed understanding of disease heritability and gene-environment interactions, India, despite its 1.4 billion population and exceptional genetic diversity, lacks a coordinated infrastructure to capitalize on this scientific opportunity. Twin studies provide nature's ideal control experiment, enabling researchers to disentangle genetic predisposition from environmental influences through comparison of monozygotic and dizygotic pairs, with discordant twins offering particularly powerful insights into modifiable risk factors. India's extraordinary genetic heterogeneity, encompassing over 4600 distinct population groups, coupled with rapid environmental transitions including urbanization, dietary shifts, and pollution exposure, creates unparalleled natural experiments for investigating conditions demonstrating marked interpopulation variation such as type 2 diabetes, cardiovascular disease, and neuropsychiatric disorders. Establishing a National Twin Registry through a federated model linking existing birth registries with opt-in research participation, leveraging digital health infrastructure like Ayushman Bharat Digital Mission, would require modest investment while generating insights applicable across the disease spectrum. Initiating pilot registries in states with robust health systems such as Kerala, Tamil Nadu or Karnataka would enable iterative refinement before national expansion. International collaborations with established registries could accelerate development while preserving data sovereignty through robust governance frameworks. A National Twin Registry represents a strategic imperative for transitioning India from a research subject pool to a research leader in precision medicine, enabling Indian investigators to drive discovery addressing India-specific health priorities.
扫码关注我们
求助内容:
应助结果提醒方式:
